Skip to main content
Fig. 3 | Nutrition Journal

Fig. 3

From: Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the “Bermuda” triangle of malnutrition-sarcopenia-frailty severely affecting prognosis

Fig. 3

Daily food intake according to the presence of dysgeusia in decompensated patients. A Daily protein intake (g/kg/die) in dACLD patients presenting and not presenting dysgeusia dACLD: decompensated advanced chronic liver disease. Mann–Whitney test. Statistically significant differences (p < 0.05). B The prevalence of individuals presenting a daily protein intake under the CPGs-recommended cut-off (1.5 g/kg/die) in dACLD patients presenting and not presenting dysgeusia CPGs: clinical practice guidelines; dACLD: decompensated advanced chronic liver disease. Chi-square test analysis. Statistically significant differences (p < 0.05). C Total energy intake (kcal/kg/die) in dACLD patients presenting and not presenting dysgeusia dACLD: decompensated advanced chronic liver disease. Mann–Whitney test. Statistically significant differences (p < 0.05). D The prevalence of individuals presenting a total energy intake under the CPGs-recommended cut-off (35 kcal/kg/die) in dACLD patients presenting and not presenting dysgeusia. CPGs: clinical practice guidelines; dACLD: decompensated advanced chronic liver disease. Chi-square test analysis. Statistically significant differences (p < 0.05)

Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us